Get startedLog in
    Picture of Valeo Pharma logo

    VPH — Valeo Pharma News Story

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareSpeculativeMicro Cap
    All News

    Brief: Newron: Zambon And Valeo Pharma Launch Onstryv For Parkinson's disease In Canada

    Picture of Valeo Pharma logoValeo Pharma
    10/07/2019 16:39
    July 10 (Reuters) - Newron Pharmaceuticals SpA  NWRN.S :
    * DGAP-NEWS: NEWRON'S COMMERCIALIZATION PARTNER ZAMBON AND
VALEO
PHARMA ANNOUNCE THE LAUNCH OF ONSTRYV(R) (SAFINAMIDE) FOR
PARKINSON'S DISEASE IN CANADA

Source text for Eikon:  ID:nEQ6gqHRma 
Further company coverage:  NWRN.S 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Valeo Pharma

    See all news